Navigation Links
Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
Date:5/19/2009

de of decline is considered clinically meaningful as a 10% decline in percent predicted FVC has been shown in multiple studies to be an independent predictor of mortality in patients with IPF. In addition, 40% more patients in the pirfenidone group did not experience a decline in percent predicted FVC at week 72 versus baseline compared to those who received placebo.

While the studies were not powered to demonstrate an effect on overall survival, a pre-specified exploratory endpoint, the pooled hazard ratio (pirfenidone: placebo) was 0.77 (p=0.326).

ADDITIONAL EXPLORATORY EFFICACY RESULTS REPORTED AT ATS

The ATS presentation highlighted new efficacy data from CAPACITY pertaining to dose-effect relationships, mean change in FVC volume and Six-Minute Walk Test distance.

Dose Relationships

In the CAPACITY 2 study, patients were randomized 2:2:1 to receive a total daily dose of 2403 mg pirfenidone, or placebo, or a total daily dose of 1197 mg pirfenidone, respectively. The lower dose of pirfenidone in CAPACITY 2 was included to explore dose-effect relationships in a descriptive fashion. Dr. Noble reported at the ATS meeting data on the low-dose pirfenidone group for the efficacy outcome measures of change in percent predicted FVC, PFS and DLco. On each of these outcome measures, the effect of 1197 mg was intermediate as compared to placebo and 2403 mg pirfenidone, indicative of a consistent dose-effect relationship. Similarly, a dose-response relationship was observed on a number of safety outcome measures.

Change in FVC Volume

Pre-specified analyses of change in FVC were based on percent predicted FVC and not volume. Given the clinical interest in FVC volume, data on change in this parameter were reported at ATS. Similar to the results of the primary endpoint analysis, evidence of a pirfenidone treatment effect on this endpoint was observed at a
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
4. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
5. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
6. AlphaVax Announces Promising Results in Melanoma Studies
7. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
8. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
9. Bionovo Announces First Quarter 2009 Highlights and Financial Results
10. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
11. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015  The Academy of Managed Care ... Administration,s (FDA,s) draft guidance and proposed rule that ... to bear a nonproprietary name with an FDA-designated ... a decision from the FDA on the naming ... stakeholders urging the agency to use the same ...
(Date:8/27/2015)... , Aug. 27, 2015  A recent ... KSSTA Knee Journal, compared the Arthrosurface HemiCAP® Wave ... design, versus an "onlay" design implant for isolated ... improvements in function and pain scores, none of ... of osteoarthritis (OA). However, 53% of the patients ...
(Date:8/27/2015)... CUPERTINO, Calif. , Aug. 27, 2015 ... management is scheduled to present at three upcoming healthcare ... , President and CEO, will present at the Rodman ... 10:00 a.m. Eastern time. The conference is being held ... York City . A live audio webcast of ...
Breaking Medicine Technology:AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3DURECT to Participate in Upcoming Healthcare Conferences 2
... SAN DIEGO, April 7, 2008 A ... shows that a proprietary blend,extracted from canola, Dermytol(TM), ... Dermytol(TM), a proprietary compound,developed by KGK Synergize Inc., ... protect skin cells from damage that may lead ...
... Research Meeting, DURHAM, N.C., April 7, 2008 ... dedicated to,treating diseases resulting from the failure of ... a Phase I clinical,safety study of a novel ... dry mouth associated with primary Sjogren,s syndrome. The,preliminary ...
Cached Medicine Technology:New Study Shows Proprietary Canola Extract, Dermytol(TM), Produces Pronounced Decrease in Malignant Melanoma Tumor Volume 2Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 2Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 3
(Date:8/28/2015)... ... August 28, 2015 , ... Santa Rosa was recently recognized, for the fourth ... Healthcare. In the KLAS “2015 Midterm Performance Review: Software & Services”, Santa Rosa achieved ... from Modern Healthcare and KLAS are directly related to our company culture.” said Richard ...
(Date:8/27/2015)... ... August 28, 2015 , ... ... out of foster care through “The Language of Flowers,” has joined the Youth ... work, particularly the organization’s YVLifeSet program, was piqued by her passion for helping ...
(Date:8/27/2015)... ... 2015 , ... According to an article published August 21st on ... the success of a patient who is attempting to lose weight. Specifically, the trial ... over that period, and compared those results with how helpful each patient felt their ...
(Date:8/27/2015)... ... August 27, 2015 , ... Workflow ... quantitative PCR (qPCR) in the last decade. New features such as ... costs. On the flipside, where do lab managers, technicians, and researchers find handy ...
(Date:8/27/2015)... , ... August 27, 2015 , ... Thriveology Founders, Dr. ... featured speakers at The Amazing Aging Expo in Denver, Colorado on Saturday, August 29, ... are consistently featured in media outlets as health authorities, and will present a two ...
Breaking Medicine News(10 mins):Health News:Santa Rosa Consulting Recognized by Modern Healthcare as One of the Top 100 Best Places to Work and from KLAS Research with the Highest Rating for Go-Live Support 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 3Health News:Article on Physician Influence on Weight Loss Highlights the Importance of a Doctor Who Cares, says Dr. Feiz & Associates 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2
... SIMI VALLEY, Calif., Oct. 10 Dr. ... maintained that techniques,exist to naturally reduce dependence on ... study published in the Journal of,Human Hypertension has ... chiropractic adjustments to correct,misalignment of the atlas vertebrae ...
... Movement, Takes on New ... Role at Dept. of State, ... Brinker, founder of Susan G. Komen for,the Cure, the world,s largest ... U.S. Department of State. Mrs. Laura Bush,was in attendance for the ...
... visit a worksite in your,community, contact Tim ... tkral@oregonrehabilitation.org , 503-585-3337. For,current photos, contact ... The Oregon Rehabilitation Association (ORA), http://www.oregonrehabilitation.org, ... with disabilities this October with National Disability,Employment ...
... Inc (OTC,Bulletin Board: NNTN) announced today that it,s ... record unaudited sales of $4,439,000 (CDN) and $601,000 ... July, August, and September 2007. Tim,Connolly, CEO of ... record,results for our first full quarter for InterACTIVE ...
... Succeed Antoine, CINCINNATI, Oct. 10, 2007 ... that Richard L. Antoine, global human resources,officer, will ... 39 years of,service. (Photo: http://www.newscom.com/cgi-bin/prnh/20071010/CLW078-a ... http://www.newscom.com/cgi-bin/prnh/20071010/CLW078-b ) In ...
... Yum! Brands Launches Global Campaign to Raise Awareness of ... WASHINGTON, Oct. 10 Friends of the World,Food ... World Hunger,Relief Week, a global consumer campaign that will ... Relief Week is spearheaded,by Yum! Brands, the world,s largest ...
Cached Medicine News:Health News:Lower Blood Pressure Without Drugs 2Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 2Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 3Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 4Health News:Revision: October is National Disability Employment Awareness Month 2Health News:Natural Nutrition Subsidiary Reports Record Third Quarter Revenue and EBITDA 2Health News:Richard L. Antoine to Retire as P&G's Global HR Officer 2Health News:Friends of WFP Welcomes 'World Hunger Relief Week' 2
... Used for temporary internal ... to the bladder. The filiform ... placement. Supplied sterile in peel-open ... CAUTION: Periodic evaluation is advised; ...
The horizontal needle box stores loaded needles according to the implant dosimetry plan. The ergonomic and lightweight design reduces time in the operating room....
The vertical needle holder conveniently positions 20 needles vertically in numbered positions for easy loading....
The Brachytherapy C-arm table is a versatile, adjustable table featuring hand and foot controls, removable sections, an X-ray film tray and grid, accessory rails and standard rail mount knee crutches...
Medicine Products: